Missre Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 08-12-2024
- Paid Up Capital ₹ 0.10 M
as on 08-12-2024
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2017)
- Profit -20.00%
(FY 2017)
- Ebitda 70.00%
(FY 2017)
- Net Worth -6.32%
(FY 2017)
- Total Assets %
(FY 2017)
About Missre Pharmaceutical
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shubhamkar Mishra and Shivamkar Misra serve as directors at the Company.
- CIN/LLPIN
U74999DL2015PTC286297
- Company No.
286297
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Oct 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Missre Pharmaceutical?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubhamkar Mishra  | Director | 12-Oct-2015 | Current |
| Shivamkar Misra | Director | 12-Oct-2015 | Current |
Financial Performance of Missre Pharmaceutical.
Missre Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 20% decrease in profit. The company's net worth dipped by a decrease of 6.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Missre Pharmaceutical?
In 2017, Missre Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pirincs Pharmaceuticals Private LimitedActive 9 years 3 daysShubhamkar Mishra and Shivamkar Misra are mutual person
- Elephanta Construction Co. Private LimitedActive 20 years 9 months
Shubhamkar Mishra and Shivamkar Misra are mutual person
- Missre Infraprojects India Private LimitedActive 9 years 9 months
Shubhamkar Mishra and Shivamkar Misra are mutual person
- Grihasti Enterprises Private LimitedActive 9 years 11 months
Shubhamkar Mishra and Shivamkar Misra are mutual person
- Mohammdi Healthcare Systems Private LimitedActive 19 years 7 months
Shubhamkar Mishra and Shivamkar Misra are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Missre Pharmaceutical?
Unlock and access historical data on people associated with Missre Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Missre Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Missre Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
